Not Tagged
Not Tagged
['tofa', 'vedolizumab', 'tofacitinib', 'vedo', 'ustekinumab', ' vedo', 'ibd']
 #ddw2023 #ibd medications are not associated with cancer risk or recurrence of cancer. we should not withhold ibd meds in pts with cancer- but individualize with our oncology team. 
Professor & Chair, Digestive Disease and Surgery Institute @ClevelandClinic Gastroenterologist in IBD patient-centered care